Financials

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current Assets:    
Cash and cash equivalents $ 350 $ 28
Prepaid expenses 483 246
Total current assets 833 274
Deposits 12 12
Operating lease right-to-use asset 72 110
Total other assets 84 122
Total assets 917 396
Current Liabilities:    
Accounts payable 2,171 1,940
Accrued expenses 1,228 2,379
Accrued interest 4,182 2,029
Operating lease liability 82 120
Line of credit 31 31
Convertible notes 23,000 13,207
Total current liabilities 30,694 19,706
Total liabilities 30,694 19,706
Stockholders' Deficit:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 77,518,614 and 69,784,699 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 78 70
Additional paid-in capital 550,984 548,096
Accumulated deficit (580,695) (567,332)
Noncontrolling interest (169) (169)
Total stockholders' deficit (29,777) (19,310)
Total liabilities and stockholders' deficit 917 396
Series C    
Stockholders' Deficit:    
Convertible preferred stock 1 1
Series J-1    
Stockholders' Deficit:    
Convertible preferred stock $ 24 $ 24

Source

v3.20.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating Expenses:        
Research and development $ (84) $ 671 $ 252 $ 1,659
Selling, general and administrative expenses 2,029 3,585 4,321 8,932
Loss on impairment 0 4,599 0 4,599
Total operating expenses 1,945 8,855 4,573 15,190
Loss from operations (1,945) (8,855) (4,573) (15,190)
Other Income (Expense):        
Loss on disposal of assets 0 (20,463) 0 (20,494)
Settlement expense 0 0 (2,563) 0
Interest expense (931) (560) (6,227) (1,493)
Total other income (expense) (931) (21,023) (8,790) (21,987)
Loss before provision for income taxes (2,876) (29,878) (13,363) (37,177)
Provision for income taxes 0 0 0 0
Net loss $ (2,876) $ (29,878) $ (13,363) $ (37,177)
Net loss per common share - basic and diluted $ (0.04) $ (0.51) $ (0.18) $ (0.69)
Weighted average common shares outstanding - basic and diluted 76,730,076 58,805,997 72,909,738 53,967,298

Source

v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (13,363) $ (37,177)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Depreciation 0 10
Stock compensation expense for options and warrants issued to employees and non-employees 327 6,202
Amortization of debt discounts 0 451
Non-cash interest expense 3,970 1,140
Loss on disposal of assets 0 20,494
Impairment of intangible assets 0 4,599
Settlement expense 2,363 0
Changes in Operating Assets and Liabilities:    
Other assets 3 6
Accounts payable and accrued liabilities 1,365 1,101
Net cash used in operating activities (5,335) (3,174)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Disposal of fixed assets 0 200
Net cash used by investing activities 0 200
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from notes payable 5,657 3,327
Repayment of note payable 0 (100)
Net cash provided by financing activities 5,657 3,227
Minority interest 0 0
Net increase (decrease) in cash and cash equivalents 322 253
Cash and cash equivalents - beginning of period 28 60
Cash and cash equivalents - end of period 350 313
Supplemental Disclosures:    
Interest paid 69 0
Income taxes paid 0 0
Issuance of common stock upon conversion of convertible notes 598 1,150
Issuance of common stock upon conversion of accrued interest $ 32 $ 14

Source